Cargando…
Limits of Peripheral Blood Mononuclear Cells for Gene Expression-Based Biomarkers in Juvenile Idiopathic Arthritis
Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic disease conditions affecting children in the USA. As with many rheumatic diseases, there is growing interest in using genomic technologies to develop biomarkers for either diagnosis or to guide treatment (“personalized medicine”)....
Autores principales: | Wong, Laiping, Jiang, Kaiyu, Chen, Yanmin, Hennon, Teresa, Holmes, Lucy, Wallace, Carol A., Jarvis, James N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935846/ https://www.ncbi.nlm.nih.gov/pubmed/27385437 http://dx.doi.org/10.1038/srep29477 |
Ejemplares similares
-
The feasibility of developing biomarkers from peripheral blood mononuclear cell RNAseq data in children with juvenile idiopathic arthritis using machine learning approaches
por: Poppenberg, Kerry E., et al.
Publicado: (2019) -
Genetic insights into juvenile idiopathic arthritis derived from deep whole genome sequencing
por: Wong, Laiping, et al.
Publicado: (2017) -
Chromatin landscapes and genetic risk for juvenile idiopathic arthritis
por: Zhu, Lisha, et al.
Publicado: (2017) -
Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis
por: Jiang, Kaiyu, et al.
Publicado: (2016) -
CD4+ T cells from children with active juvenile idiopathic arthritis show altered chromatin features associated with transcriptional abnormalities
por: Tarbell, Evan, et al.
Publicado: (2021)